Microenvironment, such as hypoxia common to cancer, plays a critical role in the epithelial-to-mesenchymal transition (EMT) program, which is a major route of cancer metastasis and confers γ-radiation resistance to cells. Herein, we showed that transgelin 2 (TAGLN2), an actin-binding protein, is significantly induced in hypoxic lung cancer cells and that Snail1 is simultaneously increased, which induces EMT by downregulating E-cadherin expression. Forced TAGLN2 expression induced severe cell death; however, a small population of cells surviving after forced TAGLN2 overexpression showed γ-radiation resistance, which might promote tumor relapse and recurrence. These surviving cells showed high metastatic activity with an increase of EMT markers including Snail1. In these cells, TAGLN2 activated the insulin-like growth factor 1 receptor β (IGF1Rβ)/PI3K/AKT pathway by recruitment of focal adhesion kinase to the IGF1R signaling complex. Activation of the IGF1Rβ/PI3K/AKT pathway also induced inactivation of glycogen synthase kinase 3β (GSK3β), which is involved in Snail1 stabilization. Therefore, both the IGF1Rβ inhibitor (AG1024) and the PI3K inhibitor (LY294002) or AKT inactivation with MK2206 lower the cellular level of Snail1. Involvement of GSK3β was also confirmed by treatment with lithium chloride, the inducer of GSK3β phosphorylation, or MG132, the 26S proteasomal inhibitor, which also stabilized Snail1. In conclusion, the present study provides important evidence that hypoxia-inducible TAGLN2 is involved in the selection of cancer cells with enhanced EMT properties to overcome the detrimental environment of cancer cells.
senescence, which is necessary for cancer cells to travel long distances from the original tumor site. 3, 4 Thus, the EMT process plays a major role in conferring cancer stem cell (CSC) properties or therapeutic resistance to cells and is consequently associated with tumor recurrence. 5, 6 Human non-small-cell lung cancer (NSCLC) cell lines with WT epidermal growth factor receptor (EGFR) show a range of sensitivity to EGFR inhibitors, such as gefitinib and erlotinib, depending on the extent to which they have undergone EMT. 7 There is also emerging evidence for a stimulating effect of therapeutic drugs and γ-radiation on phenotypic changes consistent with EMT or CSC characteristics. [8] [9] [10] Epithelial-to-mesenchymal transition is a multistep process involving disruption of intercellular adherence and increased motility, which is mainly dependent on the loss of the cell surface marker Ecadherin and the increase in mesenchymal marker proteins such as N-cadherin and vimentin. [11] [12] [13] Furthermore, several transcription factors, including zinc-finger E-box-binding homeobox (Zeb), Twist, and
Snail1 family members and their associated signaling pathways, are implicated in the phenotypic switch during the EMT process by regulating cadherin expression. 14 Thus, there is a lot to be explained regarding the molecular signal mechanism by which the expression or stabilization of these various EMT-related proteins is regulated at the beginning of EMT.
Hypoxia, a reduction in tissue oxygen tension, is a common microenvironmental stimulus that plays a critical role in embryonic development and malignant progression of tumors. 15, 16 Limited availability of oxygen determines whether cells initiate cell death or adapt to hypoxia. Small subtypes of cells can adapt to this environmental stress so that after repeated periods of hypoxia, selection for resistance to radiation therapy or chemotherapy can occur. 17, 18 Recent advances in understanding the molecular signal pathways that govern the association of hypoxia with malignant tumors also point to the importance of EMT. 19, 20 Microenvironmental conditions, such as hypoxia or inflammation in tumors, are important factors in the induction of a pathological EMT. 21, 22 Indeed, the hypoxic status of various solid tumors mediates the progression of malignant tumors by selecting cells with diminished apoptotic potential and activating genes involved in metastasis, angiogenesis, and metabolism. 23, 24 Therefore, identifying the intrinsic and extrinsic factors that induce EMT under a hypoxic environment and characterizing their signal networks will be important in overcoming the limitation of cancer therapy in several tumor types.
To date, only hypoxia-inducible factor 1 (HIF-1) and hypoxiainducible microRNA have been identified as intrinsic inducers of EMT-associated CSC properties under hypoxic microenvironmental conditions. 25, 26 HIF-1α induces Snail1, which is a central transcription regulator in EMT. 27, 28 In the present study, we showed that with an increase in Snail1, the cellular level of transgelin 2 (TAGLN2), an actin-binding protein with an ambiguous function, is also significantly induced in hypoxic conditions (0.5%~1%). In addition, hypoxiainducible TAGLN2 is involved in the selection and survival of reinforced EMT and the radiation-resistant small population of cells by enhancing stabilization of Snail1 by phosphorylation of glycogen synthase kinase 3β (GSK3β) through the focal adhesion kinase (FAK)-mediated insulin-like growth factor 1 receptor β (IGF1Rβ)/PI3K/AKT activation pathway. 
| MATERIALS AND METHODS

| Construction of TAGLN2 expression vector and transfection
To construct the TAGLN2 expression vector, a 691-bp insert of human TAGLN2 was cloned from human lung carcinoma cells poly 
| siRNAs and transfection
Chemically synthesized siRNAs were purchased from Bioneer (Daejeon, Korea) and annealed according to the manufacturer's protocol.
RNA sequences for siTAGLN2, siHIF-1α, and siAKT were as follows: 
| Flow cytometric analysis and sorting
For cell death analysis using propidium iodide (PI) staining, cells 
| Immunofluorescence staining
Cells (2 × 10 5 ) were seeded on glass coverslips in six-well plates.
After fixing with 4% paraformaldehyde followed by permeabilization with 1% Triton X-100, cells were stained with Alexa Fluor 594 phalloidin (Invitrogen) to label F-actin. Stained cells were observed under a fluorescence microscope (Olympus IX71; Olympus, Tokyo, Japan).
| Western blot analysis and immunoprecipitation
Cell lysates were prepared in RIPA buffer ( 
| Cellular assays
Cell migration/invasion assay, sphere formation assay and colony forming assay were carried out as described in a previous study. In these cells, IGF1Rβ and the AKT pathway were also activated irrespective of HIF-1α expression. TAGLN2 was also significantly induced in an HIF-1α-independent way under hypoxic conditions.
However, when TAGLN2 expression was knocked down with siRNA, the hypoxic state did not increase the cellular levels of Snail1 and did not activate IGF1Rβ as much as in control cells ( Figure 1E ). AKT activation was also slightly but clearly decreased by forced TAGLN2 suppression. These results strongly suggest that TAGLN2 can be associated with hypoxia-induced EMT through activation of the IGF1R pathway and upregulation of Snail1, irrespective of HIF-1α-mediated mesenchymal switch.
| Transgelin 2 is associated with the EMT process and resistance to γ-radiation or cytotoxic agents
We investigated whether hypoxia-inducible TAGLN2 is involved in resistance to γ-radiation and EMT, which has been recognized as a contributor to the metastatic progression of cancer. Figure 2A) . However, unexpectedly, forced TAGLN2 overexpression also significantly induced cell death and cell growth inhibition (Figure 2B ).
Necrosis has been implicated in tumor progression and aggressiveness by releasing a variety of intact cellular components including nuclear factors and cytokines into the extracellular space. 34, 35 Necrosis with late apoptosis was the most prevalent type of cell death induced by TAGLN2 overexpression ( Figure 2C , Figure S3 ).
However, Trypan blue staining showed that a small portion of cells survived after transfection of TAGLN2 overexpression vector (Figure 2D) . Subsequently, we examined the live TAGLN2-expression 
| Surviving cells selected after forced TAGLN overexpression show enhanced EMT and γ-radiationresistant properties
With the increase in EMT-associated CSC-like properties, we confirmed that after forced TAGLN2 overexpression, surviving cells show increased cell invasion and migration capacity. In contrast, TAGLN2 suppression with siRNA reduced the cell invasive and migratory behavior of lung cancer cells ( Figure 3A ,B, Figure S4 ).
EMT is closely related to increased CSC properties, which endow cancer cells with drug and γ-radiation therapeutic resistance. When cells surviving after TAGLN2 overexpression were exposed to cisplatin or γ-radiation (a single dose of 20 Gy), cell death was diminished when compared to that of the counterpart control cells. In contrast, TAGLN2 suppression with siRNA treatment significantly alleviated the resistance to cisplatin or γ-radiation ( Figure 3C ). This result strongly indicates that forced TAGLN2 overexpression or TAGLN2 induction by cytotoxic-damaging agents may also be closely related to the cell protection mechanism against anticancer agents including γ-radiation and cisplatin. In contrast, TAGLN2 suppression with siRNA treatment sensitized cells to a variety of celldamaging agents including γ-radiation ( Figure 3C ). Figure S2 ). D,E, Changes in TAGLN2, insulin-like growth factor 1 receptor (IGF1R) signaling, and representative epithelial-to-mesenchymal transition markers including E-cadherin and Snail1 under hypoxic stress (0.5%) in NSCLC cells (A549 and H460) transfected with siRNA against HIF-1α (D) or TAGLN2 (E) F I G U R E 2 Transgelin 2 (TAGLN2) is associated with the epithelial-to-mesenchymal transition process and resistance to γ-radiation or cytotoxic agents. A, Changes in colony-forming activity by TAGLN2 suppression with siRNA in A549 and H460 cells. B, Changes in colony-forming activity by TAGLN2 overexpression with pcDNA3.1-TAGLN2 expression vector in A549 and H460 cells. C, Cell death analysis by annexin V-propidium iodide (PI) staining in non-small-cell lung cancer cells transfected with TAGLN2 expression vector (see more detail in Figure S3 ). D, Identification of surviving (arrowhead) or dead cells using Trypan blue staining after TAGLN2 overexpression with pcDNA3.1-TAGLN2 expression vector in A549 or H460 cells. E, Increase in colony-forming activity in A549 and H460 cells after transfection with pcDNA3.1-TAGLN2 expression vector. F, Morphological changes and phalloidin staining of A549 and H460 cells that survived after TAGLN2 overexpression. G, Sphere-forming capacity of TAGLN2-overexpressing A549 cells. Quantified results are presented as mean ± SD (three independent experiments) using two-tailed t test. *P < .05, **P < .01, ***P < .001, ****P < .0001 were considered significant. ns, not significant; VC, vector control; Tg2, TAGLN2 F I G U R E 3 Surviving cells selected by forced transgelin 2 (TAGLN2) overexpression show epithelial-to-mesenchymal transition and γ-radiation-resistant properties. A, Expression level of TAGLN2 in A549 or H460 cells transfected with pcDNA3.1-TAGLN2 expression vector or siRNA. B, Changes in migration and invasion capacity of TAGLN2-overexpressing or suppressing A549 and H460 cells. Matrigel-coated invasion and migration chambers were used as described in Materials and Methods. C, Changes in resistance against cisplatin (20 μM) and γ-radiation (exposure to a single dose of 20 Gy using a 60 Co γ-ray source; dose rate, 2 Gy/min) in TAGLN2-overexpressing cells or TAGLN2-suppressing A549 and H460 cells. Cell death was assayed using propidium iodide staining of ethanol-fixed cells. Quantified results are presented as mean ± SD (three independent experiments) using two-tailed t test. *P < .05, **P < .01, ***P < 0.001 were considered significant. ns, not significant; VC, vector control; Tg2, TAGLN2
| Transgelin 2 recruits FAK to IGF1R to activate
IGF1Rβ and TAGLN2-induced activation of IGF1Rβ/ PI3K/AKT pathway stabilizes Snail1 protein by GSK3β inactivation
We then investigated how TAGLN2 affects tumor metastasis by EMT. With forced TAGLN2 overexpression, PI3K/AKT was significantly phosphorylated and activated in selected surviving cells (Figure 4A ). Previous studies showed that AKT activation is related to tumor metastasis as well as chemo-or radioresistance and cell growth. [36] [37] [38] The IGF1Rβ or EGFR pathway, a typical receptor tyrosine kinase (RTK), serves as a hub in the cellular PI3K/AKT activation signaling pathways that control tumor cell progression and survival.
Therefore, we investigated whether TAGLN2 overexpression is associated with IGF1Rβ activation in relation to cell survival and tumor metastasis. Forced TAGLN2 overexpression apparently increased IGF1Rβ activation ( Figure 4A ). Furthermore, TAGLN2 also partially activated EGFR, which is another upstream target of PI3K/AKT activation ( Figure 4A ). However, PTEN, which can also affect PI3K/AKT activation, was not significantly changed. By immunoprecipitation assay, we showed that direct physical interaction between TAGLN2
and IGF1Rβ can occur in vitro ( Figure 4B ). Subsequently, we investigated whether TAGLN2 interacted with SRC or FAK, a non-receptor tyrosine kinase protein (non-RTK), which are both known to activate RTK reciprocally. 39, 40 Interestingly, immunoprecipitation analysis showed that TAGLN2 directly interacted with FAK, but did not interact with SRC or JAK2, other non-RTK ( Figure 4B , Figure S5 ). Moreover, it was shown that FAK also interacts with IGF1Rβ. These results strongly indicate that FAK is recruited to IGF1Rβ by hypoxiainducible TAGLN2 to activate IGF1Rβ, and activated TAGLN2-FAK-IGF1Rβ complexes lead to subsequent PI3K and AKT activation, promoting EMT-associated self-renewal. Thus, the treatment of FAK inhibitor 14 in TAGLN2-overexpressing cells inhibited IGF1Rβ activation. Conversely, the treatment of IGF1Rβ inhibitor AG1024
inhibited FAK activation, meaning that reciprocal activation is carried out between FAK and IGF1Rβ ( Figure 4C ). Therefore, suppression of TAGLN2 expression by siRNA induced inactivation of FAK as well as inactivation of IGF1Rβ ( Figure 4D ).
We also investigated whether the IGF1Rβ/PI3K/AKT activation pathway is related to inactivation of GSK3β (phosphorylation), which inhibits phosphorylation of Snail1 and induces stabilization of this protein in EMT control. 41 We showed that treatment with the 
| Transgelin 2 induces EMT through stabilization of Snail1, a transcription repressor of Ecadherin
Hypoxia is a critical microenvironment in tumor pathogenesis, and the hypoxic responses of tumor cells are mainly regulated by HIF1, a transcription factor composed of two subunits, HIF-1α and HIF-1β.
Hypoxia induces EMT by stabilization of Snail1 by HIF-1α in a variety of tumor cells. 27, 28, 42 As shown earlier, forced TAGLN2 overexpression, which is induced by adverse environmental conditions such as hypoxia, also stabilized cellular Snail1 by inactivation of GSK3β. In addition, Slug or Twist levels were also influenced by TAGLN2 (Figure 5A ). In addition, TAGLN2 downregulated the cell surface marker E-cadherin and upregulated mesenchymal markers, such as N-cadherin and vimentin. In contrast, TAGLN2 knockdown significantly downregulated representative EMT markers ( Figure 5A ). Immunocytochemistry staining of TAGLN2 and EMT markers such as Snail1, Slug and Τwist confirmed these results ( Figure S6 ). A hallmark of EMT is the loss of E-cadherin expression, and Snail1 is closely involved in E-cadherin regulation. Snail1 binds to the E-box, which is the promoter region of E-cadherin, to inhibit the gene expression of this adhesion molecule. 43 Therefore, with TAGLN2-mediated upregulation of Snail1, the cellular E-cadherin level was significantly decreased.
Snail1 activity is regulated by various signaling pathways at multiple levels. GSK3β was shown to regulate the Snail1 level by 
| DISCUSSION
Actin is a major cytoskeleton component that participates in a variety of cellular programs, such as cell growth, cell death, migration, and cell signaling. 45 Thus, proteins binding to actin can participate in the modulation of various cellular processes. 46 Like SM22α (TAGLN) protein, TAGLN2 is also an actin-binding protein. 45, 47 cDNA-encoding TAGLN2 was first isolated from a cDNA library derived from a human immature myeloid cell line. 48 TAGLN2 is expressed in a wide variety of human tissues, including lung, liver, kidney, spleen, and thymus.
49
TAGLN2 was also identified on the membrane of human embryonic stem cells. 50 Although its localization differs among cell types, it has been reported as a membrane-associated or cytoplasmic protein. Several proteome studies reported that TAGLN2 is overexpressed in a variety of tumors and the deregulation of TAGLN2 is associated with the development of malignant tumors. [51] [52] [53] Therefore, it has been considered an important diagnostic marker of tumors. Recent studies have investigated TAGLN2-targeting microRNAs for tumor suppression. [54] [55] [56] However, despite many proteomic data, it is not fully understood how TAGLN2 acts on tumor progression and signaling pathways. In the present study, we investigated the biological roles of TAGLN2 and its underlying mechanism in depth.
The PI3K/AKT pathway regulates various cellular functions, the most important of which is the mechanism of radiation resistance in cells with EMT or CSC characteristics. PTEN is the central negative regulator of PI3K/AKT signal transduction. 57 However, PTEN cellular level was not changed by TAGLN2 suppression or overexpression, as shown in the results. Activation of IGF1Rβ, a RTK, is closely related to resistance to chemotherapy and radiotherapy in various tumor types. [58] [59] [60] We showed that IGF1Rβ, which is one of the major upstream targets of PI3K/AKT activation, undergoes 
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